A b s t r a c tAlthough
I n t r o d u c t i o n
Apoptosis, one of physiological modes of cell death, is an endogenous cell suicide mechanism that is selectively triggered in response to various stimuli (Kerr et al., 1972) . This is an active, energy-dependent process characterized by stereotypical morphological changes such as cell shrinkage, nuclear condensation, and finally fragmentation of both nucleus and cytoplasm leading to apoptotic bodies ( Wadewitz and Lockshin, 1988; Gerchenson and Rotello, 1992) . Oncogenes such as c -m y c and b c l -2 (Sullivan and Willis, 1989; Hockenbery et al., 1990) , tumor suppressor genes including R B and p 5 3 (Benveniste and Cohen, 1995; Szekely et al., 1992) , and proteolytic enzymes (Wy l l i e , 1980; Arends et al., 1990) have been reported to be associated with apoptosis. Among them, c-Myc is one of the most potent mediator for the programmed cell death. H o w e v e r, there are discrepancies in reports showing the relation of apoptosis with the regulation of c-Myc oncoprotein (Onclercq et al., 1989; Bertrand et al., 1991; Evan et al., 1992; Askew et al., 1993; Packham and Cleveland, 1995) , implicating cell specificity of regulatory mechanism.
Adenosine (Ado) is known to be an important intracellular molecule acting as an oscillator for circadian rhythm and a ubiquitous neuro-modulator in mammalian central nervous system (Sanchez, 1995; Fredholm et al. , 1994) . Since cytotoxicity of abnormally accumulated Ado, first observed in adenosine deaminase deficiency disease and severe combined immunodeficiency disease (SCID) (Giblett et al., 1972; Carson and Seegmiller, 1976; Cohen et al., 1978) , has been known to lead apoptosis, Ado is recognized as a strong inducer of apoptosis in various normal and tumor cells. Its intracellular increase in such diseases leads an idea that an Ado transporter might play an important role in the entrance of Ado into the cells (Kizaki et al., 1990; Abbrachio et al., 1995) . However, several lines of evidence suggest that Ado-induced apoptosis was mediated by Ado specific membrane-bound receptors, like its other functions (Tanaka et al., 1994; Wakade et al., 1994) .
We previously reported that apoptosis was induced by Ado in mouse leukemia L1210 cells with a preceding and transient expression of c-Myc (Kim et al., 1994) . A human leukemia cell line, HL-60 cells essentially overexpress c-Myc oncoprotein in a basal condition. Thus, the HL-60 cells might be a good model for testing the e ffects of Ado on apoptosis under c-Myc amplified state.
In this study, we examined the regulation of c-Myc oncoprotein in Ado-treated HL-60 cells as well as the entrance mechanism of Ado into the cells. We have demonstrated here that Ado-induced apoptosis in HL-60 cells, consequently resulting in rapid down-regulation of c-Myc oncoprotein before appearance of morphological apoptotic features, is mediated by active Ado transporter.
Materials and Methods

R e a g e n t s
Ado, theophylline, caffeine, dipyridamole (DPD) S-a d e n osylhomocystine (AdoHcy) were obtained from Sigma Chemical Co. (St. Louis, MO) and S-( 4 -n i t r o b e n z y 1 ) -6 -thioinosine (NBTI) was purchased from Research Biochemicals International (Natick, MA). 3-Deazaaristeromycin (DZAri) and 3-deazaadenosylhomocystine (DZAHcy) were donated by Dr. Chiang of the Walter Reed Army Institute of Research, Washington DC. Other reagents not described here were from Sigma Chemical Co. and otherwise specified.
Cell cultures and induction of apoptosis
Human promyelocytic leukemia HL-60 cells were maintained as a suspension culture in RPMI 1640 medium supplemented with 10% heat-inactivated (56˚C for 30 min) fetal bovine serum (FBS) (Hyclone, Logan, UT) and 50 μg/ml of gentamycin, 20 mM HEPES, 25 mM sodium bicarbonate in a humidified atmosphere containing 5% (v/v) CO 2 at 37˚C. To examine the effects of Ado in HL-60 cells, cells were plated at a density of 1 1 0 6 cells/ml in 12-well plates and treated with Ado. To study the signalling pathway of Ado-induced apoptosis, Ado receptor inhibitors (theophylline, 100 μM), Ado active transport inhibitor (DPD, 100 μM) or nucleoside uptake inhibitor (NBTI, 100 μM) were co-treated with Ado or pre-treated for 1 h before Ado addition. And in the test on methylation cycle intermediates were added at non-toxic doses to Ado-treated c e l l s .
DNA fragmentation analysis
After treatment, DNA was extracted from HL-60 cells as described (Lee et al., 1995) and 10 μg of extracted DNA was electrophoresed in 1.5% agarose gel. For the quantitative analysis of DNA fragmentation, the amount of intact and fragmented DNA was quantitated by the modified diphenylamine method as described. Cells were lysed with hypotonic lysis buffer (10 mM Tris, 1 mM EDTA , pH 7.5) containing 0.2% Triton X-100 and lysates were centrifuged at 13,000 g. Diphenylamine reagents [0.15 g diphenylamine (Fisher Scientific, Fairlawn, NJ), 0.15 ml sulfuric acid, 0.05 ml acetaldehyde in 10 ml glacial acetic acid] were added to each tube. After color-development overnight, optical densities were read at 570 nm. The degree of DNA fragmentation was calculated as the percentage of fragmented DNA to total DNA (sum of fragmented DNA and intact DNA).
Examination of cell morphology
Ado-treated cells were fixed for 1 h in 4F-1G fixation solution [NaH 2 P O 4 H 2 O 11.6 g, 50% (w/v) glutaraldehyde 20 ml, NaOH 2.7 g, 40% (v/v) formaldehyde 100ml, made up 1L with H 2 O]. After dehydration cells were embedded in epon resins and sectioned. The ultrathin sections were mounted on nikel grids, stained in a LKB stainer containing uranyl acetate and lead citrate, photographed with a JEM-1200 EX (Jeol, Tokyo, Japan) electron microscope at an accelerating voltage of 80 kV.
Western blot analysis
Total cellular proteins prepared from cells lysed in lysis b u ffer (Laemmli, 1975) were separated by 5-15% gradient S D S -PAGE and then electroblotted onto a nitrocellulose membrane. After blocking with 5% non-fat milk in PBS, the membrane was incubated with a mouse monoclonal antibody against human c-Myc protein (Oncogene Science, Cambridge, UK) for 1 h at room temperature. The blots were washed twice with PBS (room temperature for 15 min) and incubated with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G as a secondary antibody (Promega, Madison, WI) for 1 h at room temperature. After washing twice with PBS (room temperature for 15 min), the proteins were visualized by enhanced chemiluminescence system (Amersham, Buckinghamshire, UK). The protein bands developed in X-ray film were quantitated by Image Documentation (Stratagene, La Jolla, C A ) .
Northern blot analysis
Total RNA from HL-60 cells were extracted with RNAzol B (TEL-TEST, Inc., Friendswood, TX). Equal amount of RNA was separated on a denaturing agarose gel (1% agarose containing 2.2 M formaldehyde) and then transferred to a nylon filter (Boehringer Mannheim, Mannheim, Germany) by capillary action with 20 standard saline citrate (SSC). After the filter was UV-crosslinked (UVstratalinker 1800, Stratagene), the filter was prehybridized in high SDS buffer [7% SDS, 50% formamide, 5 S S C , 2% blocking reagent (Boehringer Mannheim, Mannheim, Germany), 50 mM sodium phosphate pH 7.0, 0.1% (w/v) N-lauroylsarcosine] at 50˚C for 2 h, and digoxigenin (DIG)-labelled human c -m y c probe prepared from specific primer and cDNA fragment (Amplimer sets, Clontech, Palo Alto, CA) by the polymerase chain reaction was added. After hybridization overnight at 50˚C, the nylon membrane was rinsed twice with 2 SSC, 0.1% SDS for 5 min at room temperature, and then sequentially washed twice with 0.1 SSC, 0.1% SDS for 15 min at 68˚C. DIG-labelled probes were detected by chemiluminescence after treatment with alkaline phosphatase-conjugated antibody against DIG and chemiluminescent substrate, disodium 3-(4-methoxys p i r o { 1 , 2 -d i o x e t a n e -3 , 2 ' -( 5 ' -c h l o r o ) t r i c y c l o [ 3 . 3 . 1 . 1 3 , 7 ] decan}-4-yl)phenylphos-phate (CSPD) (Boehringer Mannheim, Mannheim, Germany).
R e s u l t s Adenosine induces apoptosis in HL-60 cells
To assess the apoptotic effects of Ado in HL-60 cells, DNA was extracted from the cells treated with Ado and then analyzed by agarose gel electrophoresis. As shown in Figure 1B , DNA fragmentation into ladder was observed in the sample treated with 1 mM Ado. This effect of Ado for DNA fragmentation was progressively increased as time dependently as shown in Figure 1A . In these data, we demonstrated that Ado induces DNA fragmentation as a time-and dose-dependent manner, and these findings are supported by previous other reports (Kizaki et al., 1990; Tanaka et al., 1994; Wakade et al ., 1994 ; Abbrachio e t a l., 1995). The percentages of DNA fragmentation were analyzed by the modified diphenylamine method described in methods. As the time of Ado treatment was increased, the ratio of DNA fragmentation was augmented to 7% after 2 h, 17.5% after 4 h and 40.1% after 6 h ( Figure 1C) .
To further characterize the morphological effect of Ado on the HL-60 cells, the cells exposed to 100 μM of Ado were examined by transmission electron microscopy ( Figure 2 ). Untreated cells showed intact chromatin, cellular organelles and plasma membrane (Figure 2A) . After 3 h of treatment of Ado, we observed the typical apoptosis in early stage showing margination of condensed chromatin and cells are started to become fragmentation in both nucleus and cytoplasm as typical apoptotic bodies ( Figure  2B ). Apoptotic bodies were mostly shown in cells treated with Ado cells 5 h ( Figure 2C ).
In these data, we demonstrated that Ado is a very e ffective and strong inducer of apoptosis in the HL-60 cells. Judging from this time schedule of apoptosis as above, we determined the most appropriate experimental condition 
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for inducing apoptosis as incubation with 1 mM of Ado for at least 3 h, followed by all next experiment in our study.
c-Myc oncoprotein is down-regulated by Ado
Since Ado-induced apoptosis is associated with change of c-Myc oncoprotein level (Packham and Cleveland, 1995) , we tested whether the level of c-Myc oncoprotein is modulated by Ado ( Figure 3A) . The levels of protein production were determined by Western blot analysis using c-Myc antibody. As the incubation time with Ado was increased, the production of c-Myc 1 and 2 oncoproteins were rapidly reduced as a time-dependent m a n n e r. Only 54.5% of control level remained after 30 min, 22.7% after 1 h, and undetected levels after 3 h. Next we examined the transcriptional level of c-Myc in Adotreated HL-60 cells. As shown in Figure 3B , the amount of its mRNA was started to decrease after 10 min of incubation with 1 mM of Ado. While the protein was still detected up to 1 h, the expression of c-myc mRNA was not detected at the same time. This result shows that the level of c-Myc expression is down-regulated at the relatively early stage of apoptosis induced by Ado in HL-60 cells.
Active Ado transport system mediates apoptosis in HL-60 cells
Although several groups reported that the induction of apoptosis by Ado in HL-60 cells was mediated by activation of membrane-bound Ado receptors (Kizaki et al., 1990; Abbrachio et al., 1995) , Ado membrane transporter is known to be responsible for intracellular accumulation of Ado (Thampy and Barnes, 1983) , which is the major cause of apoptotic cell death in SCID patients, suggesting that the induction of apoptosis in HL-60 cells may be modulated through Ado membrane transporter. To investigate whether apoptotic cell death occurred in HL-60 cells either by Ado membrane transporter or Ado receptor, we tested the e ffects of several antagonists of Ado recepter or active Ado transport inhibitors on apoptosis of HL-60 cells treated with Ado. HL-60 cells were treated with 1 mM Ado alone or with Ado and other reagents at 100 μM. The concentration of reagents used in this study did not show any harmful effects on the proliferation or survival of HL-60 cells (data not shown). Theophyline ( Figure 4A ) and c a ffeine (data not shown) known as non-specific Ado receptor antagonists such as A1, and cyclopentylxanthine did not have any effects on DNA fragmentation induced by Ado (data not shown). However, 100 μM of DPD, well-known Ado transport inhibitor, or NBTI, a nucleoside uptake inhibitor, effectively suppressed DNA fragmentation caused by treatment of Ado for 3 h ( Figure 4A ). The blocking ability was not enough to pertain intact chromatin, but showed satisfactory results in protection from fragmentation into low molecular DNA fragments. When DPD was tested for 1 h before Ado addition, its inhibitory eff e c t disappeared (lane 7 in Figure 4B ). The results shown in Figure 4 indicate that Ado specific transporter acts as a mediator of Ado uptake into the cells, in contrast to the case of Ado receptor-mediated entrance, resulting in the induction of apoptotic cell death in HL-60 cells. Also, it was reported that from other studies that A1 and A2 Ado receptors do not have a major contribution to apoptosis in HL-60 cells (Tanaka et al., 1994; Kohno et al., 1996) . Our hypothesis inferred from the inhibitory effect of DPD on Ado-induced DNA fragmentation was tested by We s t e r n blot analysis of c-Myc oncoprotein after co-treatment of DPD with Ado in HL-60 cells. c-Myc oncoprotein was still expressed as co-treated with DPD at 100 μM, while the production of c-Myc was not observed in the cells treated with Ado alone for 3 h ( Figure 5 ). Results shown in both Figure 4 and 5 indicate that the reduction of c-Myc oncoprotein was performed by Ado which is actively transported into the cells. Additionally, incomplete recovery of c-Myc diminution, enough to relieve from the apoptotic cell death in these cells, be caused by incomplete blocking of Ado entrance by DPD.
AdoHcy has a synergistic effect on DNA fragmentation by Ado
It is well illustrated that Ado reacts with L-h o m o c y s t e i n e (Hcy) to form AdoHcy by S-adenosylhomocystine hydrolase (AdoHcyase) as the concentration of Ado was increased inside of the cells. The increased concentration of AdoHcy potently inhibits S-a d e n o s y l -L-m e t h i o n i n emediated reactions, which modulate donation of methyl groups to DNA, RNA, and protein (Cantoni et al., 1979) , resulting in hypersensitivity of the hypomethylated DNA to nucleases (Lewis and Bird, 1991) . Loennechen et al. (1989) reported that methylation cycle was interrupted by DZAri (Lewis and Bird, 1991) , a potent inhibitor of AdoHcyase (Kim et al., 1982) , DZAHcy, and AdoHcy.
To investigate the effects of methylation intermediates on Ado cytotoxicity in HL-60 cells, we exmined the DNA fragmentation followed by co-treatment of Ado with A d o H c y. In the experiment shown in Figure 6 , DNA fragmentation was stimulated at the marginal level when either AdoHcy or DZAHcy was treated with DZAri, a potent inhibitor of AdoHcyase. In cells that Ado was cotreated with AdoHcy or DZAHcy, however, Ado-induced DNA fragmentation was stimulated more than two times that expected if they acted additively. Therefore, these reagents are able to cooperate to produce synergistic stimulation of Ado-induced DNA fragmentation. This observation suggests that the accumulation of AdoHcy and DZAHcy leads to inhibit to S-adenosyl L-m e t h i o n i n e mediated DNA to nuclease. Therefore, it seems that apoptosis may be due to the combined action with a methylation-dependent manner of DNA.
D i s c u s s i o n
We have demonstrated that Ado-induced apoptosis in HL-60 cells is mediated through an active Ado transporter, consequently resulting in rapid down-regulation of c-Myc oncoprotein before appearance of morphological apoptotic features. The rapid reduction of c-Myc expression in both mRNA and protein level indicates that the production of cMyc oncoprotein is regulated in early step of the apoptotic process in response to Ado surpassing threshold level. Our data show that reduction of c-Myc level lasted for 6 h describes that apoptosis is a stochastic process, with individual cells committing to the programmed death over an extended time (Packham and Cleveland, 1995) . Human promyelocytic leukemia HL-60 cells are tumor cells that constitutively express large amount of c-Myc proteins (Little et al., 1983) . It seems that these cells respond to the powerful signals of proliferation which is originated from overexpression of c-Myc and take place as stable tumor cells, perhaps through obtaining circumstance which supplies factors for survival apoptotic suppression, as in the rare reports (Ryan and Birnie, 1996) . Our results that DNA ladder formation was inhibited by DPD, a Ado transporter inhibitor, however, it was not influenced by specific Ado receptor antagonists ( Figure  4B ) suggest that DNA fragmentation is may be mediated come from membrane-bounded Ado receptors. Also, several lines of evidence in other studies suggested that Ado-induced apoptosis in HL-60 cells was not mediated by Ado-specific A1 or A2 receptor. Tanaka et al. (1994) demonstrated that poly-(ADP-ribosyl)ation, one of early event in apoptosis, was effectively reduced at 100 times lower concentration of DPD than that of Ado (10 μM versus 1 mM). However, the concentration of DPD at 10 μM was deficient for demoting Ado effect under threshold level and it was necessary for satisfactory result in blocking the formation of DNA ladder at 10 times higher dose. A recent study that Ado cytotoxicity was almost completely protected in neuronal cells when Ado was treated with either Ado-transporter inhibitors such as dilazep or NBTI in the culture indicates that Ado-induced apoptosis may be mediated through an Ado transporter in sympathetic neurons (Wakade et al., 1995) . In contrast, Kohno et al. (1996) reported that Ado A3 receptor agonist induced apoptosis in HL-60 cells, which is a membrane-mediated p a t h w a y. They were still able to detect A3 receptor mRNA in the absence of Ado A3 receptor agonist. One possible explanation proposes that Ado acts differently from its specific receptor analogs in the induction mechanism of apoptosis, although we presently do not know exact action mechanism of apoptotic pathway.
It is likely that affinity of DPD or NBTI to a transporter is much higher than that of Ado, showing that they eff e c t i v e l y inhibited DNA fragmentation even at 10 times lower concentration (100 μM versus 1 mM) (Figure 4) . Cells that were treated with DPD for 1 h before Ado addition could not neutralize the Ado effect on Ado-induced DNA fragmentation ( Figure 4B ). The reason for this observation is unclear, but several explanations are possible. First, DPD may be held by Ado transporter and then recycled to plasma membrane. Second, DPD may be rapidly degraded after endocytosis through membrane. Third, DPD has no ability to regulate the programmed cell death like Ado itself. Although DPD gave satisfactory results in blocking DNA fragmentation (Figure 4) , it did not provide any meaningful recovery of c-Myc level ( Figure 5 ). From these results, we inferred that blocking of Ado entrance into the cells by DPD was not complete, allowing just weak recovery of cMyc reduction, which, however, protected successfully DNA fragmentation, we describe here that the role of cMyc protein was dependent on the amount of its expression level, not on the presence of the oncoprotein.
Other reports that inhibition of the methylation reaction had an important role in SCID pathogenesis (German e t a l., 1983) suggest that Ado-induced apoptosis may be correlated with methylation reactions. In this paper, we tested the effect of AdoHcy or DZAHcy to assess the specific mechanism of Ado-induced apoptosis. AdoHcy, which is accumulated due to inhibition of the S-a d e n o s y lhomocysteine hydrolase, and DZAHcy, its stable analog, inhibit the activity of methyltransferase (Garcia et al., 1983; Backlund et al., 1986) . It was demonstrated that DNA from HL-60 cells exposed to DZA and DZAri, a specific AdoHcy hydrolase inhibitor, was hypomethylated (Loennechen e t a l., 1989) . It is clear that the methylation is known to influence chromatin structures and nonmethylated DNAs have a higher sensitivity to degradation by nucleases than methylated DNAs (Lewis and Bird, 1991) . Although DZAHcy or AdoHcy alone did not have any effects on apoptosis of HL-60 cells, consistent with other studies (Endresen et al., 1993; Wakade et al., 1995) , synergistic activity of DNA fragmentation between these agents and Ado has potential implications for the regulation of Adoinduced apoptosis of HL-60 cells through perturbance of m e t h y l a t i o n .
Although c-Myc oncoprotein has important roles in cell cycle progression and transformation, its correlation with apoptosis does not have general agreement owing to specificity in cell types and stimuli. Recent studies demonstrate that reduction of its endogenous level had an obligatory role in the induction of apoptotic cell death regardless of constitutive amount of c-Myc oncoprotein (Packham and Cleveland, 1995) . HL-60 cells may loose endogenous c-Myc level in apoptosis. However, stimulation of endogenous c-Myc oncoprotein was also reported to trigger apoptosis in other cell types (Evan et al., 1992; Kim et al ., 1994) . There is no direct evidence that presents requirement of cell cycle progression as c-Myc induces apoptosis and that demonstrates relationship between cMyc and Ado-induced apoptosis (Kimura et al., 1995) . The direct evidence for the role of c-Myc in Ado-induced apoptosis of c-Myc amplified HL-60 cells will be supported i f apoptosis is inhibited by maintenance of stable expression of c-Myc using potent vehicles in Ado-treated HL-60 cells.
